GPs' willingness to prescribe aspirin for cancer preventive therapy in Lynch syndrome: a factorial randomised trial investigating factors influencing decisions.
Kelly E LloydLouise Hazel HallLucy E ZieglerRobbie FoyGillian M BorthwickMairead MacKenzieDavid G TaylorSamuel George Smithnull nullPublished in: The British journal of general practice : the journal of the Royal College of General Practitioners (2023)
It is unlikely that providing information on clinical guidance, trial results, and information comparing benefits and harms will increase aspirin prescribing for Lynch syndrome in primary care. Alternative multilevel strategies to support informed prescribing may be warranted.
Keyphrases
- primary care
- low dose
- study protocol
- cardiovascular events
- case report
- papillary thyroid
- antiplatelet therapy
- general practice
- health information
- clinical trial
- healthcare
- phase iii
- open label
- randomized controlled trial
- adverse drug
- type diabetes
- bone marrow
- cardiovascular disease
- acute coronary syndrome
- young adults
- squamous cell
- percutaneous coronary intervention
- coronary artery disease
- phase ii
- double blind
- lymph node metastasis